You're using an older browser that may not provide the best experience on our site - for optimal performance and security, please update your browser.
Past performance is not indicative of future results. The value of fund units/shares can rise as well as fall and you may not get back the amount you invested. Funds with a risk level of 5-7 according to the fund’s key information document (KID) can both decrease and increase significantly in value. Fund information, including the KID, prospectus, and sustainability-related disclosures can be found at Our Luxembourg funds.
SEB Concept Biotechnology, the merging fund, was merged with SEB Läkemedelsfond, the receiving fund, on 8 September 2025. Following the merger, the merging fund was dissolved.
Customers who had investments in SEB Concept Biotechnology are encouraged to read the information about the merger that was published on this website on 2 June 2025: SEB Concept Biotechnology merges with SEB Läkemedelsfond